Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
May 27, 2026, 08:31 ET Wet AMD Market Set for Robust Growth Through 2036, Driven by Advancements in Anti-VEGF Therapies | DelveInsight
Ophthalmics, Annexon Biosciences, NGM Biopharmaceuticals, Ionis Pharmaceuticals, Apellis Pharmaceuticals, Iveric Bio, Gyroscope Therapeutics, Novartis, Luxa Biotechnology, Gemini Therapeutics, and others.
More news about: DelveInsight Business Research, LLP
Feb 25, 2026, 09:00 ET Foundation Fighting Blindness to Host Free Webinar on Regenerative Medicine Advances for Retinal Diseases
Association for Research in Vision and Ophthalmology (ARVO).Jeff Stern, PhD, MD, is founder and chief medical officer of Luxa Biotechnology, where he is developing dry AMD treatment using RPE cell therapies. A retinal specialist with a PhD in biophysics and an MD in ophthalmology,
More news about: Foundation Fighting Blindness